MF
Mani Foroohar Leerink Partners Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
14
Avg Return
Past Year
Past Year
5.7%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
58.3%
Neutral
25%
Negative
16.7%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Health Information Services
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $29 |
94%
upside
| 1 | -12% |
0
%
| 3 Mar ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $104 |
41%
upside
| 2 | -5% |
0
%
| 3 Mar ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $118 |
17%
upside
| 1 | -15% |
0
%
| 26 Feb ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $20 |
183%
upside
| 1 | -35% |
0
%
| 15 Dec ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $86 |
26%
upside
| 1 | -5.5% |
0
%
| 15 Dec ‘25 6 months ago |
|
|
|
Market Perform
Maintained
| $351 |
22%
upside
| 1 | – |
–
| 15 Dec ‘25 6 months ago |
|
|
|
Underperform
Maintained
| $18 |
65%
downside
| 2 | -60% |
0
%
| 21 Nov ‘25 6 months ago |
|
|
|
Outperform
Maintained
| $20 |
330%
upside
| 2 | +70% |
0
%
| 7 Oct ‘25 8 months ago |
|
|
|
Market Perform
Maintained
| $7 |
145%
upside
| 2 | -83% |
–
| 3 Oct ‘25 8 months ago |
|
|
|
Market Perform
Downgraded
| $10 |
37%
downside
| 1 | – |
–
| 21 Jul ‘25 11 months ago |
|